Toggle navigation
Home
Search
Services
Blog
Contact
About
Astatine-211 Labeled Antibodies for Therapy
Wilbur, D Scott
Neorx Corporation, Seattle, WA, United States
Search 444 grants from D Wilbur
Search grants from Neorx Corporation
Share this grant:
:
:
Abstract
Funding
Institution
Related projects
Comments
Recent in Grantomics:
University of Maryland Baltimore
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
Air Pollution and the Lung in Health and COPD: Obstructive, Restrictive and Vascular Pathways
Alcohol and Adult Development: Understanding Etiology and Consequences
Treatment of Hypoxia Resistance in Pancreatic Cancer - Clinical
Nimh Collaborative HIV/Std Prevention Trial
Spect Brain Imaging In Neuropsychiatric Disorders
Recently added grants:
Uncleaved prefusion-optimized trimers on nanoparticles as HIV vaccines
Development of pH-Sensitive Probes for in vivo Cerenkov Imaging
Recombinant HIV-1 Env glycoprotein immunogens and antibodies production and structural characterization
Development of prime-boost immunization schemes to elicit VRC01-class bNAbs in polyclonal human BCR backgrounds
Evaluating anti-idiotypic antibodies as novel vaccine candidates against HIV-1
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
Division of Cancer Treatment (NCI)
Type
Small Business Innovation Research – Phase I (N43)
Project #
N43CM067941-001
Application #
3614582
Study Section
Project Start
1986-09-24
Project End
Budget Start
1986-11-01
Budget End
1987-03-31
Support Year
Fiscal Year
1987
Total Cost
Indirect Cost
Institution
Name
Neorx Corporation
Department
Type
DUNS #
City
Seattle
State
WA
Country
United States
Zip Code
98119
Related projects
NIH 1987
N43 CM
Astatine-211 Labeled Antibodies for Therapy
Wilbur, D Scott / Neorx Corporation
NIH 1986
N43 CM
Astatine-211 Labeled Antibodies for Therapy
Wilbur, D Scott / Neorx Corporation
Comments
Be the first to comment on this grant